The BioFire® Respiratory 2.1
(RP2.1) Panel (EUA)*

SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The BioFire RP2.1 Panel (EUA) is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.

Click here for information on BioFire’s additional COVID-19 solutions.